Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care

• Status: Completed
• Trial end date: 2013-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This controlled study will test the effectiveness of a stepped-care approach to a standard behavioral weight loss treatment for obese patients with Binge Eating Disorder (BED). The major question is whether the stepped-care approach, which begins with behavioral weight loss and then follows a decision tree for additional interventions based on early treatment response is superior to standard behavioral treatment.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Yale University
• Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Treatments: Orlistat; Sibutramine

Criteria

Inclusion criteria:

• Obese (BMI>=30)

Exclusion criteria:

• Medication regimen that represents medical contraindication to sibutramine

• Serious unstable or uncontrolled medical conditions that represent contraindication to sibutramine

• Pregnancy